Malignant Melanoma

Showing NaN - NaN of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

Malignant Melanoma Trial in Los Angeles, Houston, Uppsala (delolimogene mupadenorepvec, atezolizumab)

Recruiting
  • Malignant Melanoma
  • delolimogene mupadenorepvec
  • atezolizumab
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in United States (ZN-c3)

Recruiting
  • Solid Tumor
  • +9 more
  • Tucson, Arizona
  • +3 more
Aug 12, 2021

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +7 more
Jul 20, 2020

Malignant Melanoma Trial in Houston (Vincristine Sulfate Liposomes Injection)

Completed
  • Malignant Melanoma
  • Vincristine Sulfate Liposomes Injection
  • Houston, Texas
    University of Texas M.D. Anderson Cancer Center
Dec 10, 2019

Malignant Melanoma Trial in Houston (CC-5013)

Completed
  • Malignant Melanoma
  • Houston, Texas
    MD Anderson Cancer Center
Nov 6, 2019

Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)

Completed
  • Malignant Melanoma
  • Birmingham, Alabama
  • +111 more
Oct 16, 2019

Malignant Melanoma Trial in United States (HF10 plus Ipilimumab)

Completed
  • Malignant Melanoma
  • HF10 plus Ipilimumab
  • San Francisco, California
  • +7 more
Sep 25, 2018

Malignant Melanoma Trial in Worldwide (Ipilimumab)

Terminated
  • Malignant Melanoma
  • Ipilimumab
  • Phoenix, Arizona
  • +31 more
Jul 31, 2017

Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)

Completed
  • Malignant Melanoma
  • Colorectal Carcinoma
  • Los Angeles, California
  • +6 more
Aug 18, 2017

Malignant Melanoma Trial in Australia, United States (vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +14 more
Jun 26, 2017

Malignant Melanoma Trial in Canada, United States (Nivolumab, Ipilimumab)

No longer available
  • Malignant Melanoma
  • Gilbert, Arizona
  • +65 more
Feb 6, 2017

Malignant Melanoma Trial in Worldwide (vemurafenib)

Terminated
  • Malignant Melanoma
  • Los Angeles, California
  • +25 more
Aug 25, 2016

Malignant Melanoma Trial in Worldwide (HSPPC-96 or Oncophage)

Completed
  • Malignant Melanoma
  • HSPPC-96 or Oncophage
  • Birmingham, Alabama
  • +76 more
Sep 6, 2012

Malignant Melanoma Trial in United States (CP-675,206)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
Jun 5, 2012

Melanoma, Metastatic Melanoma, Malignant Melanoma Trial in United States (Allovectin-7®)

Completed
  • Melanoma
  • +3 more
  • Allovectin-7®
  • Tucson, Arizona
  • +15 more
Jul 5, 2011

Malignant Melanoma, Tumor Metastasis Trial in Houston (investigational drug INGN 241)

Unknown status
  • Malignant Melanoma
  • Neoplasm Metastasis
  • investigational drug INGN 241
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 28, 2008

Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

Unknown status
  • Malignant Melanoma
  • CancerVax vaccine (CANVAXIN)
  • Tucson, Arizona
  • +79 more
Jun 23, 2005

Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

Unknown status
  • Malignant Melanoma
  • CancerVax vaccine (CANVAXIN)
  • Tucson, Arizona
  • +76 more
Jun 23, 2005